MARKETS / NASDAQ / AIFF
NASDAQ · SERVICES-PREPACKAGED SOFTWARE · SMALL CAP

Firefly Neuroscience, Inc. AIFF

16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.1M
▲ 957.4% vs FY2024
EPS · FY25
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-547.6%
Net margin · FY25
-1741.0%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.1M
Revenue, FY2025 · full 16-year series below
Revenue Net income
0.0040.0080.0120.0160.0-0.0201020132016201920222025
0.0040.0080.0120.0160.0-0.02016201920222025

The company lost 1741 cents on every revenue dollar this year.

Per share
Diluted EPS, FY2025
EPS
0.40.81.2201020132016201920222025
0.40.81.22016201920222025

The company pays no cash dividend.

Profitability
-547.6%
Return on equity, FY2025
ROE
8162432-547.6%201020132016201920222025
8162432-547.6%2016201920222025
Operating margin-775.5%
Net margin-1741.0%
Return on assets-263.7%

Each USD of equity lost 548 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
−39.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−53.0%
−39.3%
−15.6%
−11.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2025
0.010.01201020132016201920222025
0.010.012016201920222025
Change, 5 years+0.5%
Change, 10 years+0.6%

The share count grew 1% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.5M
total assets, end of FY2025
Total assetsUSD 10.5M
EquityUSD 7.6M
Current ratio1.43×

Equity funds 73% of total assets.

History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
Income tax $B
0.0
−0.0
0.0
0.0
−0.0
0.0
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
EPS, diluted $
·
·
·
·
−0.09
0.03
−0.06
0.00
0.02
−0.05
0.01
0.00
−0.01
0.01
0.01
0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−547.6
·
·
−233.4
−11.9
29.8
−47.3
−2.7
14.0
−29.1
3.7
−1.4
−2.8
4.8
7.8
7.8
Shares out B
0.01
0.01
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
60 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed